AEROSOL CHARACTERISTICS OF TC-99M-PENTETIC ACID (DTPA) AND SYNTHETIC SURFACTANT (EXOSURF)

被引:9
作者
COLEMAN, RE
MACINTYRE, N
SNYDER, G
PATTISHALL, E
ZACCARDELLI, D
机构
[1] DUKE UNIV,MED CTR,DEPT INTERNAL MED,DURHAM,NC 27710
[2] BURROUGHS WELLCOME CO,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1378/chest.105.6.1765
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This study evaluated the feasibility of using Tc-99m-pentetic acid (DTPA) as a radioactive tracer for aerosolized synthetic surfactant (DPPC, cetyl alcohol, tyloxapol). The Tc-99m-DTPA was admired with surfactant and aerosolized using a nebulizer system interfaced to a ventilator with a cascade impactor attached to the endotracheal tube. Particle size distribution for DPPC, cetyl alcohol, and Tc-99m-DTPA were almost identical during the 0- to 15-, 15- to 30-, and 0- to 30-min collection periods. Tyloxapol exhibited a unique distribution pattern with increased deposition in large (>10 mu m) and small (0.65 to 1.1 mu m) particles. The mass median aerodynamic diameter for all aerosolized components was in the respirable range of 2.1 to 2.5 mu m. A mixture of Tc-99m-DTPA with synthetic surfactant appears to be a reasonable method to evaluate surfactant deposition.
引用
收藏
页码:1765 / 1769
页数:5
相关论文
共 10 条
[1]  
Dolovich M, 1991, RESPIR CARE, V36, P931
[2]  
DUSSER DJ, 1986, AM REV RESPIR DIS, V134, P493
[3]  
KACMAREK R M, 1991, Respiratory Care, V36, P952
[4]  
LEWIS J, 1991, American Review of Respiratory Disease, V143, pA769
[5]   AEROSOL DELIVERY IN INTUBATED, MECHANICALLY VENTILATED PATIENTS [J].
MACINTYRE, NR ;
SILVER, RM ;
MILLER, CW ;
SCHULER, F ;
COLEMAN, RE .
CRITICAL CARE MEDICINE, 1985, 13 (02) :81-84
[6]  
SVEDMYR N, 1991, Respiratory Care, V36, P922
[7]   INCREASED PULMONARY ALVEOLAR-CAPILLARY PERMEABILITY IN PATIENTS AT RISK FOR ADULT RESPIRATORY-DISTRESS SYNDROME [J].
TENNENBERG, SD ;
JACOBS, MP ;
SOLOMKIN, JS ;
EHLERS, NA ;
HURST, JM .
CRITICAL CARE MEDICINE, 1987, 15 (04) :289-293
[8]  
WEG J, 1991, CHEST, V100, pS137
[9]  
WIEDEMANN H, 1992, American Review of Respiratory Disease, V145, pA184
[10]  
1991, RESPIR CARE, V36, P916